L. Chaperot, N. Bendriss, and O. Manches, Identification of a leukemic counterpart of the plasmacytoid dendritic cells, Blood, vol.97, issue.10, pp.3210-3217, 2001.
DOI : 10.1182/blood.V97.10.3210

S. Swerdlow, E. Campo, and N. Harris, World Health Organisation Classification of Tumors, 2008.

A. Jegalian, N. Buxbaum, and F. Facchetti, Blastic plasmacytoid dendritic cell neoplasm in children: diagnostic features and clinical implications, Haematologica, vol.95, issue.11, pp.1873-1879, 2010.
DOI : 10.3324/haematol.2010.026179

URL : http://doi.org/10.3324/haematol.2010.026179

K. Sakashita, S. Saito, and R. Yanagisawa, Usefulness of allogeneic hematopoietic stem cell transplantation in first complete remission for pediatric blastic plasmacytoid dendritic cell neoplasm with skin involvement: A case report and review of literature, Pediatric Blood & Cancer, vol.36, issue.11, pp.140-142, 2013.
DOI : 10.1002/pbc.24622

F. Julia, T. Petrella, and M. Beylot-barry, Blastic plasmacytoid dendritic cell neoplasm: clinical features in 90 patients, British Journal of Dermatology, vol.118, issue.3, pp.579-586, 2013.
DOI : 10.1111/bjd.12412

T. Petrella, C. Meijer, and S. Dalac, TCL1 and CLA Expression in Agranular CD4/CD56 Hematodermic Neoplasms (Blastic NK-Cell Lymphomas) and Leukemia Cutis, American Journal of Clinical Pathology, vol.122, issue.2
DOI : 10.1309/0QPPAVTUPCV9UCLV

F. Angelot-delettre, S. Biichle, and C. Ferrand, Intracytoplasmic detection of TCL1-but not ILT7-by flow cytometry is useful for blastic plasmacytoid dendritic cell leukemia diagnosis, Cytometry Part A, vol.66, issue.8, pp.718-724, 2012.
DOI : 10.1002/cyto.a.22072

URL : https://hal.archives-ouvertes.fr/inserm-00718156

F. Garnache-ottou, J. Feuillard, and C. Ferrand, Extended diagnostic criteria for plasmacytoid dendritic cell leukaemia, British Journal of Haematology, vol.75, issue.5, pp.624-636, 2009.
DOI : 10.1111/j.1365-2141.2009.07679.x

URL : https://hal.archives-ouvertes.fr/hal-00451257

T. Marafioti, J. Paterson, and E. Ballabio, Novel markers of normal and neoplastic human plasmacytoid dendritic cells, Blood, vol.111, issue.7, pp.3778-3792, 2008.
DOI : 10.1182/blood-2007-10-117531

T. Petrella, M. Bagot, and R. Willemze, Blastic NK-Cell Lymphomas (Agranular CD4+CD56+ Hematodermic Neoplasms), American Journal of Clinical Pathology, vol.123, issue.5, pp.662-675, 2005.
DOI : 10.1309/GJWNPD8HU5MAJ837

S. Dalle, M. Beylot-barry, and M. Bagot, Blastic plasmacytoid dendritic cell neoplasm: is transplantation the treatment of choice?, British Journal of Dermatology, vol.91, issue.1, pp.74-79, 2009.
DOI : 10.1111/j.1365-2133.2009.09373.x

S. Dietrich, M. Andrulis, and U. Hegenbart, Blastic Plasmacytoid Dendritic Cell Neoplasia (BPDC) in Elderly Patients: Results of a Treatment Algorithm Employing Allogeneic Stem Cell Transplantation with Moderately Reduced Conditioning Intensity, Biology of Blood and Marrow Transplantation, vol.17, issue.8, pp.1250-1254, 2011.
DOI : 10.1016/j.bbmt.2010.12.706

D. Roos-weil, S. Dietrich, and A. Boumendil, Stem cell transplantation can provide durable disease control in blastic plasmacytoid dendritic cell neoplasm: a retrospective study from the European Group for Blood and Marrow Transplantation, Blood, vol.121, issue.3, pp.440-446, 2013.
DOI : 10.1182/blood-2012-08-448613

L. Gilis, L. Lebras, and F. Bouafia-sauvy, Sequential combination of high dose methotrexate and L-asparaginase followed by allogeneic transplant: a first-line strategy for CD4+

L. Pagano, C. Valentini, and A. Pulsoni, Blastic plasmacytoid dendritic cell neoplasm with leukemic presentation: an Italian multicenter study, Haematologica, vol.98, issue.2, pp.239-246, 2013.
DOI : 10.3324/haematol.2012.072645

P. Piccaluga, S. Paolini, M. Sapienza, and S. Pileri, Blastic plasmacytoid dendritic cell neoplasm: is it time to redefine the standard of care?, Expert Review of Hematology, vol.5, issue.4, pp.353-355, 2012.
DOI : 10.1586/ehm.12.33

M. Ramanathan, J. Cerny, H. Yu, B. Woda, and R. Nath, A combination treatment approach and cord blood stem cell transplant for blastic plasmacytoid dendritic cell neoplasm, Haematologica, vol.98, issue.3, p.36, 2013.
DOI : 10.3324/haematol.2012.080051

W. Blalock and C. Weinstein-oppenheimer, Signal transduction, cell cycle regulatory, and anti-apoptotic pathways regulated by IL-3 in hematopoietic cells: possible sites for intervention with anti-neoplastic drugs, Leukemia, vol.13, issue.8, pp.1109-1166, 1999.
DOI : 10.1038/sj.leu.2401493

A. Miyajima, T. Kitamura, N. Harada, T. Yokota, and K. Arai, Cytokine Receptors and Signal Transduction, Annual Review of Immunology, vol.10, issue.1, pp.295-331, 1992.
DOI : 10.1146/annurev.iy.10.040192.001455

A. Frankel, J. Ramage, M. Kiser, R. Alexander, G. Kucera et al., Characterization of diphtheria fusion proteins targeted to the human interleukin-3 receptor, Protein Engineering Design and Selection, vol.13, issue.8, pp.575-581, 2000.
DOI : 10.1093/protein/13.8.575

A. Rapoport, S. Luhowskyj, P. Doshi, and J. Dipersio, Mutational analysis of the alpha subunit of the human interleukin-3 receptor, Blood, vol.87, issue.1, pp.112-122, 1996.

R. Kreitman, A. Frankel, J. Liu, D. Rizzieri, and D. Hogge, Recombinant immunotoxins containing truncated bacterial toxins for the treatment of hematologic malignancies Phase I clinical study of diphtheria toxininterleukin 3 fusion protein in patients with acute myeloid leukemia and myelodysplasia, BioDrugs. Leuk Lymphoma, vol.2349, issue.233, pp.1-13543, 2008.

A. Frankel, J. Woo, and C. Ahn, Activity of SL-401, a targeted therapy directed to interleukin-3 receptor, in blastic plasmacytoid dendritic cell neoplasm patients, Blood, vol.124, issue.3, pp.385-392, 2014.
DOI : 10.1182/blood-2014-04-566737

S. Perruche, F. Kleinclauss, A. Lienard, R. E. Tiberghien, P. Saas et al., A singleplatform approach using flow cytometry and microbeads to evaluate immune reconstitution in mice after bone marrow trans- plantation

A. Frankel, J. Mccubrey, and M. Miller, Diphtheria toxin fused to human interleukin-3 is toxic to blasts from patients with myeloid leukemias, Leukemia, vol.14, issue.4, pp.576-585, 2000.
DOI : 10.1038/sj.leu.2401743

J. Black, J. Mccubrey, M. Willingham, J. Ramage, D. Hogge et al., Diphtheria toxin-interleukin-3 fusion protein (DT388IL3) prolongs disease-free survival of leukemic immunocompromised mice, Leukemia, vol.17, issue.1, pp.155-159, 2003.
DOI : 10.1038/sj.leu.2402744

M. Feuring-buske, A. Frankel, R. Alexander, G. B. Hogge, and D. , A diphtheria toxin-interleukin 3 fusion protein is cytotoxic to primitive acute myeloid leukemia progenitors but spares normal progenitors, Cancer Res, vol.62, issue.6, pp.1730-1736, 2002.

R. Alexander, J. Ramage, G. Kucera, M. Caligiuri, and A. Frankel, High affinity interleukin-3 receptor expression on blasts from patients with acute myelogenous leukemia correlates with cytotoxicity of a diphtheria toxin/IL-3 fusion protein, Leukemia Research, vol.25, issue.10, pp.875-881, 2001.
DOI : 10.1016/S0145-2126(01)00034-0

D. Hogge, L. Yalcintepe, S. Wong, G. B. Frankel, and A. , Variant Diphtheria Toxin-Interleukin-3 Fusion Proteins with Increased Receptor Affinity Have Enhanced Cytotoxicity against Acute Myeloid Leukemia Progenitors, Clinical Cancer Research, vol.12, issue.4, pp.1284-1291, 2006.
DOI : 10.1158/1078-0432.CCR-05-2070

Y. Su, S. Li, S. Ghosh, J. Ortiz, D. Hogge et al., Characterization of variant diphtheria toxin???interleukin-3 fusion protein, DTIL3K116W, for phase I clinical trials, Biologicals, vol.38, issue.1, pp.144-149, 2010.
DOI : 10.1016/j.biologicals.2009.08.016

F. Angelot-delettre, A. Frankel, and J. Liu, The IL-3Ra-targeted drug SL-401 selectively kills blastic plasmacytoid dendritic cell neoplasm cells, Blood, vol.118, p.2588, 2011.

G. Grouard, M. Rissoan, L. Filgueira, I. Durand, J. Banchereau et al., The Enigmatic Plasmacytoid T Cells Develop into Dendritic Cells with Interleukin (IL)-3 and CD40-Ligand, The Journal of Experimental Medicine, vol.153, issue.6, pp.1101-1111, 1997.
DOI : 10.1084/jem.185.2.341

B. Amor, R. Hicheri, Y. Pautas, and C. , Successful Non-Myeloablative Allogeneic HLA-Identical Stem Cell Transplantation for CD4/CD56 Positive Acute Leukemia, Transplantation, vol.84, issue.8, pp.1066-1067, 2007.
DOI : 10.1097/01.tp.0000286098.28481.7d

J. Fontaine, L. Thomas, and B. Balme, Haematodermic CD4+CD56+ neoplasm: complete remission after methotrexate-asparaginase treatment, Clinical and Experimental Dermatology, vol.58, issue.5, pp.43-45, 2009.
DOI : 10.1111/j.1365-2230.2008.03100.x

B. Gruson, I. Vaida, and L. Merlusca, L-asparaginase with methotrexate and dexamethasone is an effective treatment combination in blastic plasmacytoid dendritic cell neoplasm, British Journal of Haematology, vol.34, issue.4, pp.543-545, 2013.
DOI : 10.1111/bjh.12523

J. Leitenberger, C. Berthelot, K. Polder, and P. , CD4+ CD56+ hematodermic/plasmacytoid dendritic cell tumor with response to pralatrexate, Journal of the American Academy of Dermatology, vol.58, issue.3, pp.480-484, 2008.
DOI : 10.1016/j.jaad.2007.12.012

M. Narita, T. Kuroha, and N. Watanabe, Plasmacytoid Dendritic Cell Leukemia with Potent Antigen-Presenting Ability, Acta Haematologica, vol.120, issue.2, pp.91-99, 2008.
DOI : 10.1159/000165510

A. Agliano, I. Martin-padura, and P. Marighetti, Therapeutic Effect of Lenalidomide in a Novel Xenograft Mouse Model of Human Blastic NK Cell Lymphoma/Blastic Plasmacytoid Dendritic Cell Neoplasm, Clinical Cancer Research, vol.17, issue.19, pp.6163-6173, 2011.
DOI : 10.1158/1078-0432.CCR-11-0212

J. Menezes, F. Acquadro, and M. Wiseman, Exome sequencing reveals novel and recurrent mutations with clinical impact in blastic plasmacytoid dendritic cell neoplasm, Leukemia, vol.10, issue.4, pp.823-829, 2014.
DOI : 10.1038/nrd3943

M. Sapienza, F. Fuligni, and C. Agostinelli, Molecular profiling of blastic plasmacytoid dendritic cell neoplasm reveals a unique pattern and suggests selective sensitivity to NF-kB pathway inhibition, Leukemia, vol.406, issue.8, pp.1606-1616, 2014.
DOI : 10.1200/JCO.2012.42.5611

A. Hertler, D. Schlossman, M. Borowitz, D. Poplack, and A. Frankel, An immunotoxin for the treatment of T-acute lymphoblastic leukemic meningitis: studies in rhesus monkeys, Cancer Immunology Immunotherapy, vol.28, issue.1, pp.59-66, 1989.
DOI : 10.1007/BF00205802